tiprankstipranks
Lipigon Pharmaceuticals AB (DE:9RP)
FRANKFURT:9RP
Germany Market
9RP
Lipigon Pharmaceuticals AB
RESEARCH TOOLSreports

Lipigon Pharmaceuticals AB (9RP) Income Statement

0 Followers

Lipigon Pharmaceuticals AB Income Statement

Last quarter (Q4 2025), Lipigon Pharmaceuticals AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q4, Lipigon Pharmaceuticals AB's net income was kr-7.18M. See Lipigon Pharmaceuticals AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 10.29Mkr 16.41Mkr 390.00Kkr 3.18M
Gross Profit
kr -83.00Kkr -26.29Mkr -5.12Mkr 366.00Kkr -36.04M
Operating Expenses
kr 31.68Mkr 7.16Mkr 7.25Mkr 37.74Mkr 555.00K
Depreciation and Amortization
kr 83.00Kkr 59.00Kkr 24.00Kkr 24.00Kkr 23.00K
EBITDA
kr -31.68Mkr -25.14Mkr -12.10Mkr -37.68Mkr -41.09M
Operating Income
kr -31.77Mkr -25.58Mkr -12.37Mkr -37.74Mkr -41.19M
Other Income/Expenses
kr -673.00Kkr 312.00Kkr 243.00Kkr 37.00Kkr 78.00K
Pretax Income
kr -32.44Mkr -25.26Mkr -12.13Mkr -37.70Mkr -41.11M
Net Income
kr -32.44Mkr -25.26Mkr -12.13Mkr -37.67Mkr -41.12M
Per Share Metrics
Basic EPS
kr -0.08kr -0.18kr -0.19kr -2.12kr -3.35
Diluted EPS
kr -0.08kr -0.18kr -0.19kr -2.12kr -3.35
Weighted Average Shares Outstanding
 403.83M 138.41M 64.12M 17.79M 12.27M
Weighted Average Shares Outstanding (Diluted)
 403.83M 138.41M 64.12M 17.79M 12.27M
Currency in SEK

Lipigon Pharmaceuticals AB Earnings and Revenue History